Table 1.
Clinical and functional data for patients (n = 27) with interstitial pulmonary fibrosis (IPF)
| Characteristics | |
| Age (years) | 65.3 ± 12.4 |
| Duration of disease (years) | 2.9 ± 2.7 |
| Sex ratio (M/F), no. | 22/5 |
| Mortality (%) | 44% (12/27) |
| Survival (years) | 1.5 ± 1.2 |
| Duration of follow-up (years) | 3.4 ± 1.2 |
| Smoking status, n (pack-years) | |
| Current smoker | 4 (45 ± 5) |
| Former smoker | 12 (27 ± 12) |
| Never smoker | 11 |
| Lung function tests | |
| FVC (L) | 2.3 ± 0.9 |
| FVC (% predicted) | 71 ± 26 |
| DLCO (% predicted) | 41 ± 16 |
| Distance traveled during 6MWT (meters) (meters) (meters)=21) | 457 ± 76 |
| PaO2 (mmHg) | 69.2 ± 9.1 |
| PaCO2 (mmHg) | 36.8 ± 2.6 |
| Bronchoalveolar lavage cytology (n = 19) Cellularity (x103/mL) | 263 ± 19 |
| Macrophages (%) | 62.0 ± 4.6 |
| Lymphocytes (%) | 9.3 ± 1.6 |
| Neutrophils (%) | 22.2 ± 5.0 |
| Eosinophils (%) | 2.5 ± 1.6 |
Data are mean ± SD unless indicated